Your browser doesn't support javascript.
loading
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand, Romain; Peltier, Alexandre; Roche, Jean-Baptiste; Lievore, Elena; Lacetera, Vito; Chiacchio, Giuseppe; Beatrici, Valerio; Mastroianni, Riccardo; Simone, Giuseppe; Windisch, Olivier; Benamran, Daniel; Fourcade, Alexandre; Nguyen, Truong A; Fournier, Georges; Fiard, Gaelle; Ploussard, Guillaume; Roumeguère, Thierry; Albisinni, Simone.
Affiliation
  • Diamand R; Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
  • Peltier A; Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
  • Roche JB; Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
  • Lievore E; Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
  • Lacetera V; Department of Urology, IRCCS IEO Istituto Europeo di Oncologia, Milan, Italy.
  • Chiacchio G; Department of Urology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
  • Beatrici V; Department of Urology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
  • Mastroianni R; Department of Urology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
  • Simone G; Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Windisch O; Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
  • Benamran D; Department of Urology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Fourcade A; Department of Urology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Nguyen TA; Department of Urology, Hôpital Cavale Blanche, CHRU Brest, Brest, France.
  • Fournier G; Department of Urology, Hôpital Cavale Blanche, CHRU Brest, Brest, France.
  • Fiard G; Department of Urology, Hôpital Cavale Blanche, CHRU Brest, Brest, France.
  • Ploussard G; Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC, Grenoble, France.
  • Roumeguère T; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France.
  • Albisinni S; Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Prostate ; 83(6): 572-579, 2023 05.
Article de En | MEDLINE | ID: mdl-36705314
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Biopsie / Antigène spécifique de la prostate Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Prostate Année: 2023 Type de document: Article Pays d'affiliation: Belgique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Biopsie / Antigène spécifique de la prostate Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Prostate Année: 2023 Type de document: Article Pays d'affiliation: Belgique